Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,530 | -4,390 | -8,940 | -1,840 | -1,540 |
| Depreciation Amortization | 3,080 | 1,530 | 880 | 550 | 370 |
| Accounts receivable | N/A | N/A | -1,292 | N/A | N/A |
| Other Working Capital | -1,930 | 130 | -320 | -2,260 | -1,320 |
| Other Operating Activity | 210 | 130 | 2,942 | 0 | 10 |
| Operating Cash Flow | $-8,170 | $-2,600 | $-6,730 | $-3,550 | $-2,480 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 71 | N/A | N/A |
| PPE Investments | -2,180 | -220 | -450 | -140 | -80 |
| Net Acquisitions | 0 | 0 | 1,320 | 0 | 0 |
| Other Investing Activity | -5,810 | -11,640 | -11 | -980 | -510 |
| Investing Cash Flow | $-7,990 | $-11,860 | $930 | $-1,120 | $-590 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 221 | N/A | N/A |
| Other Financing Activity | 15,630 | 15,330 | 12,619 | 4,680 | 4,370 |
| Financing Cash Flow | $15,630 | $15,330 | $12,840 | $4,680 | $4,370 |
| Beginning Cash Position | 7,410 | 7,410 | 370 | 1,300 | 1,300 |
| End Cash Position | 6,870 | 8,280 | 7,410 | 1,310 | 2,600 |
| Net Cash Flow | $-530 | $860 | $7,040 | $10 | $1,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,170 | -2,600 | -6,730 | -3,550 | -2,480 |
| Capital Expenditure | N/A | N/A | -457 | N/A | N/A |
| Free Cash Flow | -8,170 | -2,600 | -7,187 | -3,550 | -2,480 |